Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
May 27, 2025
Join us in San Francisco, CA, USA, July 12-15, 2025, for ENDO 2025. With over 7,000 attendees, nearly 2,500 abstracts and over 200 other sessions, ENDO is the leading global meeting on endocrinology research and clinical care. ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world.
June 13, 2025
Registration is open for our leading online training program for fellows, residents, and physicians preparing for the board certification exam. Maximize your score in Endocrinology, Diabetes, & Metabolism with a study guide and expert insights. Registration includes a printed book, interactive practice exams, and topical Q&A sessions. Register now
June 13, 2025
Discover the latest advances in hormone health treatments at CEU 2025 on October 23- 25. Our comprehensive, case-based agenda will help you gain new skills that you can immediately apply in your practice. Join the best in clinical sessions covering nine topical categories and earn up to 27 AMA PRA Category 1 Credits™. Eligible physicians may also claim up to 9 ABIM MOC Points. Register today
June 04, 2025
Navigate the complexities of endocrine care for children and adolescents with the Pediatric Endocrine Self-Assessment Program (ESAP)™ 2025–2026. Enhance patient care with 100 new case-based questions covering growth, diabetes, reproduction, and more. Available in print, eBook, and online, with interactive modes to build knowledge and confidence. Order now.
July 11, 2025
In celebration of ENDO this week, check out the Society's advocacy accomplishment's since ENDO 2024 in Boston.
Need more info?
Learn more about the advantages of membership
July 12, 2025
Strong emotional links between children with chronic conditions and their family caregivers suggest that improving parent well-being may directly benefit a child’s overall health and coping mechanisms, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
July 12, 2025
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
July 12, 2025
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
July 08, 2025
The authors present a 38-year-old woman with bilateral nodular adrenal disease with corticotropin independent Cushing syndrome.
July 08, 2025
Combined ultrasound with elastography has been proposed as an adjunct to ultrasound in the assessment of thyroid nodules because malignant nodules are harder (therefore stiffer) than benign ones.
July 08, 2025
We evaluated provider sentiments and practices that influence recommendations for insulin pump use.
